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Abstract
Objectives—To describe the prevalence of epilepsy after 6 months-of-age in children with perinatal
stroke and examine whether perinatal data predict epilepsy onset and resolution.
Study design—A retrospective review of 64 children with perinatal stroke. In children with at
least 6 months of follow-up data, Kaplan-Meier curves, univariate log-rank tests, and Cox
proportional hazards models were used to examine predictors of time to development of seizures,
and time to resolution of seizures in children with epilepsy. The association of risk factors with the
presence of epilepsy at any time after 6 months-of-age was examined using Fisher’s exact test.
Results—Forty-one of the 61 children with at least 6 months of follow-up data (67%) had epilepsy
between 6 months-of-age and last follow-up, but in 13 of 41 seizures eventually resolved and
anticonvulsants were discontinued. Infarct on prenatal ultrasound (p=0.0065) and family history of
epilepsy (p=0.0093) were significantly associated with time to development of seizures after 6
months-of-age in the univariate analysis. No assessed variables were associated with time to
resolution of epilepsy or with the presence of epilepsy after 6 months-of-age.
Conclusions—Childhood epilepsy is frequent after perinatal stroke. Evidence of infarction on
prenatal ultrasound and a family history of epilepsy predict earlier onset of active seizures.
Epilepsy affects approximately 5 out of 1000 children; however, children with central nervous
system injury are at increased risk1. Children with perinatal arterial ischemic stroke appear to
be at increased risk for childhood epilepsy, but estimates of epilepsy after perinatal stroke vary
widely. Epilepsy rates ranging from 0–50%2–9 were reported for studies of 8–46 children with
a median of approximately 35 months of follow-up. There are few studies examining clinical
factors that predict the development of childhood epilepsy in children with perinatal stroke,
and little data on when children with perinatal stroke develop epilepsy. When parents are told
that their child had a perinatal stroke and the possible outcomes are described, physicians are
often faced with the following three questions: will my child have epilepsy when he is older?
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If my child does have epilepsy, will the medication stop all his seizures? When would he
develop seizures? The purpose of this study is to answer these questions by describing the
prevalence and severity of epilepsy after 6 months-of-age in children with perinatal stroke,
examine whether data present in the perinatal period predict the presence of childhood epilepsy,
describe when these children develop active seizures and examine predictors of time to onset
of seizure activity.
Methods
Population
Sixty-four children with perinatal arterial ischemic stroke were initially identified using a
combination of the following techniques: review of neurology clinic records from January
1990-January 2007; patient referral; and International Classification of Disease, 9th edition
code searches from May 1 1999-May 1 2004 using codes 767 (neonatal stroke), 433 (occlusion
and stenosis/precerebral ischemia), 434 (occlusion of cerebral arteries), 435 (transient cerebral
ischemia), 436 (acute but ill-defined cerebrovascular disease), 437 (other and ill-defined
cerebrovascular disease), 438 (late effects of cerebrovascular disease) and 342 (acute
hemiplegia)10. ICD-9 codes searches of additional years were not performed due to the
limitations of these searches.11 Birth years of patients ranged from 1990–2005. The perinatal
period was defined as the time from the end of the 20th week of gestation to day 28 after
birth12. All children had a gestational age of at least 36 weeks at birth, presented with
neurological symptoms during the neonatal period (first 28 days of life) and were diagnosed
with arterial ischemic stroke before discharge home from the neonatal intensive care unit
(NICU). Children with radiographic evidence of generalized hypoxic ischemic injury or
dysmorphic features suggestive of a genetic syndrome were excluded.
Data Collection
Data were collected from the medical record on prenatal ultrasound imaging abnormalities,
clinical presentation, perinatal comorbidities, initial cranial computed tomography (CT) and/
or magnetic resonance imaging (MRI), initial and follow-up electroencephalograms (EEG),
family history of epilepsy in first- or second-degree relatives, and epilepsy status during all
available follow-up. Based on radiographic findings, stroke locations were identified,
described by arterial territory, and classified as unilateral or bilateral. Unilateral middle cerebral
artery (MCA) infarctions were classified as large branch (involving the M1 territory) or small
branch. EEG reports were reviewed and classified as normal or abnormal. Abnormalities were
classified as abnormal background consistent with encephalopathy, slowing or voltage
attenuation, epileptiform discharges, or electrographic seizure activity. Epilepsy outcomes
were assessed in children at least 6 months-of-age at the last clinical follow-up. All subjects
had clinic notes that included the clinician’s record of last seizure and estimated frequency of
seizures. Children were classified as having or not having epilepsy, and were classified
according to a modified form of the Engel classification13, 14 adjusted by our group for a
young population with limited follow-up and no surgical intervention: Class 0= seizure-free
and off anticonvulsants for at least 6 months, Class 1= seizure-free for at least 6 months while
on medication or seizure-free off medication for fewer than 6 months, Class 2= less than one
seizure a month, Class 3= 1–4 seizures a month, Class 4= 5–30 seizures a month, Class 5= 30
or more seizures a month. Epilepsy was defined as modified Engel (ME) class 1 or higher,
active seizures were defined as ME class 2 or higher, and severe epilepsy was defined as ME
class 3 or higher. All children with epilepsy had at least 2 nonfebrile clinical seizures or 1
nonfebrile clinical seizure with an EEG demonstrating epileptiform discharges.
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Statistical Analysis
Totals and proportions were used to describe the clinical characteristics of the population. Time
to development of first seizure after six months-of-age was the primary outcome examined.
Six months-of-age was chosen as a starting point because in our clinical experience children
with perinatal stroke are often maintained on phenobarbital for up to 6 months after NICU
discharge; we wanted to examine what happens after that point. For children who presented
with seizures at six months-of-age, the time to first seizure was zero. For children who never
developed seizures, the time to first seizure was length of follow-up, and the observation was
censored.
Time to resolution of seizures was also examined; in some children with epilepsy, seizures
resolve and anticonvulsants can be discontinued. This analysis only included children who had
seizures after six months-of-age. For children whose seizures resolved, defined as both being
seizure-free for at least 6 months and being taken off anticovulsants, the time to seizure
resolution was months from start of seizures to date taken off anticonvulsants. For children
whose seizures did not resolve, the time to seizure resolution was months from start of seizures
to date of last follow-up, and the observation was censored.
Six variables were examined as predictors of outcome: evidence of infarction on prenatal
ultrasound; initial presentation with seizures; abnormality on initial NICU EEG; presence of
bilateral infarcts on radiographic imaging; in children with MCA infarcts, the presence of large-
versus-small-branch infarction; and family history of seizures. Univariate log-rank tests were
done to test the association of each of these factors with time to development of seizures. Last,
a multivariable Cox proportional hazards model was fit to examine the association of all factors
except abnormality on initial NICU EEG and the presence of large-versus-small-branch MCA
infarction. Abnormality on initial NICU EEG was omitted because no children with evidence
of stroke on prenatal ultrasound had a neonatal EEG. The presence of large-versus-small-
branch infarction was omitted because it did not apply to children who did not have an MCA
infarction. The proportional hazards assumption was tested with the Kolmogorov-type
supremum test for all variables and was met in all cases.
As a secondary analysis, Fisher’s exact tests were done to examine the association of the six
factors with development of epilepsy at any time after six months-of-age (yes/no).
Ethics
This study was approved by the Institutional Review Board of the Indiana University School
of Medicine (Study # 0207-55)
Results
Patient population
Sixty-four children with perinatal arterial ischemic stroke were identified. Thirty-six (56%)
were male. Forty-eight (75%) presented in the NICU with seizures. All children with seizures
were treated with phenobarbital. Additional medications used included lorazepam (8),
phenytoin (8), diazepam (1) and fosphenytoin (1). Additional presentations which prompted
neurological evaluation included apnea (19), respiratory distress (12), abnormal tone (11), poor
feeding (9), poor respiratory effort (6), and irritability (5). Cormorbidities included infection
in 11 (17%); cardiac abnormalities in 11 (17%); extracorporeal membrane oxygenation in 4
(6%), and renal failure in 3 (5%). Seven of the 64 children with perinatal arterial ischemic
stroke (11%) had a family history of seizures.
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Radiographic Findings
Evidence of stroke was present on prenatal ultrasound for 4 patients (6%). All patients had
confirmation of infarction by cranial CT (20), MRI (20), or both (24). Forty-six children (72%)
had unilateral hemispheric infarction in isolated arterial territories: 1 in the right internal carotid
artery territory, 1 in the right anterior cerebral artery (ACA) territory, 4 in the posterior cerebral
artery (PCA) territory (2 left, 2 right) and 40 in the MCA territory (27 left, 13 right). Of the
unilateral MCA infarctions, 18 were large branch and 19 were small branch; original films
could not be accessed for 3 and infarction size could not be judged from radiographic reports.
Four children had multiple unilateral infarctions in multiple territories. Fourteen children had
bilateral infarctions involving the following regions: the basal ganglia (1 right), brainstem (1),
cerebellar (1 left, 2 right), anterior cerebral artery (2 left, 2 right), PCA (7 left, 7 right), and
MCA (12 left, 11 right) territories. Four had watershed infarctions. Nineteen had infarction
with hemorrhagic transformation (9 left, 3 right, 7 bilateral).
Initial EEG findings on reports
Initial EEG reports were available for 44 of the 48 newborns that presented with seizures; 40
(91%) had at least one abnormality on initial EEG. (Table I; available at www.jpeds.com)
Epilepsy status after 6 months-of-age
At least 6 months of follow-up data were available on 61 patients (95% of 64). Median age of
these 61 patients at last follow-up was 43 months (range 9–179). Forty-one children (67 %)
had epilepsy (ME class 1 or higher) between 6 months-of-age and last follow-up. Eleven of
those children were maintained on phenobarbital after NICU discharge for more than 6 months,
but were seizure-free (ME class 1); children were maintained on phenobarbital for that length
of time usually due to abnormal EEG or variations in physician practice. Eleven children had
seizure activity after leaving the NICU which continued or started in the first 6 months of life
(ME class 2 or higher). Nineteen children had seizure onset after 6 months of age; 6 of those
children had not presented with seizures in the NICU. Median age at onset of seizures for those
19 children was 16 months (range 7–124 months). Seizures resolved in 13 (32% of 41 children
with epilepsy); these children were seizure-free and off medications for at least 6 months at
the last follow-up visit.
A total of 28 children (46% of the 61 included patients) were classified as having epilepsy at
the time of last follow-up (Table II). Five children (8% of the 61 children) developed infantile
spasms; these children have been previously described15. Most of the children with epilepsy
(64%; 18 of 28) were seizure-free on medication or while being weaned off.
Twenty-five patients were on seizure medications at last follow-up; 3 had been weaned off but
had been seizure-free off medication for fewer than 6 months. The most commonly used
medications used at last follow up were: phenobarbital (10), lamotrigine(5), oxcarbazepine (7),
valproic acid (4), and topiramate(4). Six (24% of the 25 patients with medication) patients
required multiple medications to control their seizures at last follow-up.
Follow-up EEGs performed at 6 months-of-age or later were available for 42 of the children:
17 were normal; 19 had slowing and/or voltage attenuation, which was diffuse in 9 and focal
in 10; 19 had epileptiform discharges. Five children had infantile spasms with onset at a median
age of 7 months; three of these children later developed severe seizures (ME class 3 or higher).
Several of these children were previously described.15 The Kaplan-Meier curve demonstrating
the probability of being seizure-free (ME class 0 or 1) over time is in Figure 1.
On univariate analysis, only presence of infarct on prenatal ultrasound (p=0.0065) (Figure 2;
available at www.jpeds.com) and family history of seizures (p=0.0093) (Figure 3; available at
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www.jpeds.com) were significantly associated with time to development of seizures after six
months of age. The median time to development of seizures after 6 months-of-age was shorter
in children with evidence of infarct on prenatal ultrasound (3.8 months with evidence vs 53.9
without evidence) and in children with a family history of seizures (1.1 months with a family
history vs 53.9 months without). Results of the log-rank tests are shown in Table III. On
multivariable analysis, none of the variables were associated with time until development of
seizures, though there was a trend towards significance for presence of infarct on prenatal
ultrasound and family history of seizures: presence of infarct on prenatal ultrasound (p=0.053),
NICU presentation with seizures (p=0.397), bilateral infarcts (p=0.826), family history
(p=0.087).
On univariate analysis, no variables were significantly associated with time to resolution of
seizures after six months-of-age. Results of the log-rank tests are shown in Table IV. On
multivariable analysis, none of the variables with significantly associated with time to
resolution of seizures: presence of infarct on prenatal ultrasound (p=0.998), NICU presentation
with seizures (p=0.874), bilateral infarcts (p=0.998), or family history (p=0.874).
None of the six factors were significantly associated with development of seizures at any time
after six months of age on Fisher’s exact tests. These results are shown in Table V (available
at www.jpeds.com).
Discussion
Seizures are a frequent presenting sign of perinatal arterial ischemic stroke, and childhood
epilepsy is a frequent resulting morbidity. In our cohort, 75% (48 of 64) of children with
perinatal stroke presented with seizures, and 67 % (41 of 61 with >= 6 months of follow-up)
had or developed epilepsy after 6 months-of-age. Epilepsy resolved in 13 children, so 46% (28
of 61) had epilepsy as of last follow-up. Sixty-four percent (18 of 28) of the children with
epilepsy were eventually seizure-free with treatment and 25 % (7 of 28) of the children with
epilepsy had severe epilepsy at last follow-up with 1 or more seizures per month (ME class 3
or higher). Seizures that started or re-started after 6 months-of-age began at a median age of
16 months, but one child had seizures start at 10.3 years of age. Evidence of infarct on prenatal
ultrasound and family history of epilepsy were both associated with earlier onset of seizures.
We were unable to identify predictors of what caused epilepsy to resolve in some children, or
whether or not children would develop epilepsy.
This prevalence of childhood epilepsy after perinatal stroke was higher than what has been
reported in previous studies2–9, but we did note that seizures resolved in some children; our
incidence of epilepsy at last follow-up falls within the previously described range. There are
larger studies of epilepsy in the hemiplegic cerebral palsy literature, where it is reported
approximately 1/3 of children have epilepsy16, 17; in this population, neonatal seizures are a
predictor for later seizures18. In our cohort, neonatal seizures did not predict later epilepsy.
Stroke is responsible for at least 20% of hemiplegic cerebral palsy19, 20, but the wide range
of other etiologies included in this population makes it difficult to draw conclusions on the
outcomes after perinatal stroke from published cerebral palsy data.
The median age at time of seizure development for children over 6 months-of-age in our cohort
was 16 months (range 7 months to 10 years and 4 months). Sran et al2 described children with
perinatal stroke who were seizure-free for 1–8 years, then developed epilepsy. It is possible
that the incidence of epilepsy after perinatal stroke in our cohort will rise as we continue to
follow these children over the next several years.
Evidence of infarction on prenatal ultrasound predicted the earlier onset of epilepsy in our
cohort. There are few large studies of fetal stroke, but the data that have been published suggest
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that these children may be at increased risk for neurological impairment. Ozduman et al21
described epilepsy in 2 of 3 children with fetal stroke who had at least 18 months of follow-
up; they reviewed the previous literature but few details on the long-term neurological
outcomes were available.
Family history was also a predictor of the development of seizures over time; children
developed epilepsy earlier if they had a family history of epilepsy. This suggests that genetic
background may influence outcome, but may also reflect increased awareness and detection
of seizures in families with prior experience with epilepsy.
Although we found predictors of time to onset of epilepsy, none of the risk factors we evaluated
predicted time to resolution of seizures or whether children would develop epilepsy. Lee and
colleagues also found it difficult to identify predictors of epilepsy6. Our sample size may have
limited our ability to identify strong predictors. We may be able to revisit this in future, larger
studies.
There are several limitations in this study. Most of the data are retrospective. We started to
collect prospective data on some of these children two years ago, but the rarity of perinatal
stroke makes it difficult to collect information on large numbers of children at a single center.
Our cohort may have been too small to detect variables predictive of later epilepsy due to type
II error. We have limited follow-up, with a median age at last follow-up of 43 months; some
of the children developed epilepsy as late as 10 years of age, so we may have underestimated
the rate of childhood epilepsy. It is also possible that some of the children whose epilepsy
“resolved” will have their epilepsy restart later in life. This cohort may be biased towards sicker
patients who have higher rates of epilepsy. Some children with perinatal stroke have normal
neurological outcomes22; their parents might be less likely to return for follow-up. Some of
the children who were “well-controlled on one medication” may have had resolution of their
epilepsy that was not detected because follow-up EEG was not performed. We had 11 children
who were maintained on phenobarbital for more than 6 months after NICU discharge, in part
because there are no well-established guidelines on how long to maintain anticonvulsant
therapy in children with neonatal stroke. However, for a parent, a child who has epilepsy and
is “well-controlled on medication” and a child who is actually epilepsy-free but still on
medication require the same amount of work. For parents, the experienced outcome is the same,
so we felt it was reasonable to group them together. For the Kaplan-Meier curves and Cox
proportional hazards models, we chose to examine time to development of active seizures after
6 months-of-age becasue it was not always clear when epilepsy began and ended for children
maintained on phenobarbital while seizure-free for prolonged periods. The object of this paper
was to provide information to counsel parents about future care their children would require.
In the future, when we have more follow-up data on these children, we may find it easier to
identify predictors of chronic epilepsy.
Previous work has suggested that abnormal background on neonatal EEG or early seizures may
be predictive of later poor neuromotor outcome3, 7. The next step in our research will be to
examine other outcome measures and see if this holds true in our cohort. We will also assess
the association of epilepsy with other disability.
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Figure 1.
The light dotted lines represent 95% confidence intervals.
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Figure 2.
Comparison of children with and without evidence of infarction prenatal ultrasound, difference
is significant, p= 0.0065
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Figure 3.
Comparison of children with and without family history of epilepsy, difference is significant,
p=0.0093.
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Table I
EEG findings on initial EEG (n= 44*)
EEG finding # (%)
Abnormal background 26 (59.1%)
Slowing/voltage attenuation 26 (59.1%)
Epileptiform discharges 35 (79.5%)
Electrographic seizures 17 (38.6%)
Normal 4 (9.1%)
*
Not all children had initial EEG performed
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Table II
Epilepsy outcomes at last follow-up (N=61)
Outcome # (%)
ME Class 0 33 (54%)
ME Class 1 18 (30%)
ME Class 2 3 (5%)
ME Class 3 4 (7%)
ME-Class 4 2 (3%)
ME-Class 5 1 (2%)
Infantile spasms 5 (8%)
ME= Modified Engel
Class 0= seizure-free and off anticonvulsants for at least 6 months
Class 1= seizure-free on medication for at least 6 months or seizure-free off medication for fewer than 6 months
Class 2= less than one seizure a month
Class 3= 1–4 seizures a month
Class 4= 5–30 seizures a month
Class 5= 30 or more seizures a month.
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Table III
Log-rank tests- Prediction of time to seizure onset after 6 months
N Median months p-value
Evidence of infarct on ultrasound 4 3.8 0.007
No evidence of infarct on ultrasound 57 53.9
Initial presentation with seizures 45 53.9 0.890
No initial presentation with seizures 16 111.8
Abnormal NICU EEG 40 31.4 0.701
Normal NICU EEG 5 >53.5
Bilateral infarcts 13 31.4 0.772
No bilateral infarcts 48 53.9
MCA infarct- Large branch 18 111.8 0.718
MCA infarct- Small branch 18 53.9
Family history 7 1.1 0.009
No family history 54 53.9
NICU= neonatal intensive care unit; EEG= electroencephalogram;
MCA= middle cerebral artery
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Table IV
Log-rank tests- Predictors of resolution of epilepsy
N Median months p-value
Presence of infarct on prenatal ultrasonography 4 >178.8 0.2535
No presence of infarct on prenatal ultrasonography 26 >152.9
Initial presentation with seizures 21 >88.0 0.2609
No initial presentation with seizures 9 >178.8
Abnormal NICU EEG 20 >150.5 0.3830
Normal NICU EEG 2 >78.4
Bilateral infarcts 7 >152.9 0.2619
No bilateral infarcts 23 >178.8
Family history of epilepsy 6 >178.8 0.7023
No family history of epilepsy 24 >152.9
Large branch 9 >178.8 0.0984
Small branch 8 65.4
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Table V
Fisher’s exact test- predictors of epilepsy
p-value
Evidence of infarct on ultrasound 0.293
Initial presentation with seizures 0.356
Abnormal NICU EEG 0.136
Bilateral infarcts 0.742
MCA infarcts: Large vs. small branch 0.443
Family history 0.409
NICU= neonatal intensive care unit; EEG= electroencephalogram;
MCA= middle cerebral artery
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